Assessment of AI Performance in Detecting Breast Lesions on MRI: A Retrospective Study in a Chinese Cohort
Insights into Imaging / ECR / 2025 / conference
Bayer S, Bhandary Panambur A, Du X, Grimm R, Von Busch H, Maier A, Huang J, Lui S
Scientific summary
This retrospective breast MRI study evaluates lesion-level AI performance in an external Chinese cohort, with emphasis on sensitivity and false-positive burden.
Abstract
This ECR 2025 exhibit evaluates an AI model for suspicious breast lesion detection in breast MRI scans from a Chinese cohort.
Why it matters
External cohort validation is essential for assessing whether breast MRI AI systems can support high-volume screening without unacceptable false-positive rates.
Contribution
It reports retrospective performance of a Siemens Healthineers breast MRI research prototype on West China Hospital data.
Method overview
The study sampled 200 cases from a 4,000-patient breast MRI cohort and used multi-sequence 3T MRI with expert lesion annotations.
Key findings
- The EPOS poster reports case-level sensitivity of 0.906.
- The poster reports median 0 false positives per case and average 0.635 false positives per case.
- The cohort came from West China Hospital MRI exams between November 2017 and August 2023.
Citation
Bayer S, Bhandary Panambur A, Du X, Grimm R, Von Busch H, Maier A, Huang J, Lui S. (2025). Assessment of AI Performance in Detecting Breast Lesions on MRI: A Retrospective Study in a Chinese Cohort. Insights into Imaging / ECR.
TODO: Add BibTeX.